Links2HealthierBubs: Influenza And Pertussis Vaccine Effectiveness And Safety In Pregnancy
Funder
National Health and Medical Research Council
Funding Amount
$676,333.00
Summary
Vaccination during pregnancy can offer protection against severe respiratory disease for infants in the first six months of life. For this reason, influenza and pertussis vaccines are routinely recommended during each pregnancy. Unfortunately, little is known about the ‘real world’ effect of both vaccines. We plan to conduct the largest and most comprehensive study to date to evaluate all vaccines routinely recommended in pregnancy in Australia.
Early Indicators Of Noise Injury: Are Decreased Auditory Processing Skills Evident In Noise-exposed Adults Prior To Diagnosis Of Hearing Loss?
Funder
National Health and Medical Research Council
Funding Amount
$367,605.00
Summary
Recent research indicates that noise-exposed individuals with similar hearing thresholds to non-noise exposed counterparts are more likely to have diminished temporal and spectral auditory processing abilities. This research aims to determine the relationship between noise exposure levels and auditory processing difficulties; the influence of musical training in ameliorating these difficulties; and a neurological model of causation, operation and possible remediation of these difficulties.
Kidney Function And The Effectiveness And Safety Of Direct Oral Anticoagulants In Atrial Fibrillation: The KODIAK-AF Study
Funder
National Health and Medical Research Council
Funding Amount
$451,730.00
Summary
The direct oral anticoagulants (DOACs) are a relatively new type of drug that are used to prevent the onset of stroke among patients with atrial fibrillation (AF). While these drugs have been demonstrated to be safe and effective among AF patients, in those AF patients with chronic kidney disease (CKD), there is uncertainty as to whether these drugs are similarly safe. This program of research will study the safety profile of DOACs in patients with AF and CKD.
A Pragmatic Randomised Clinical Trial Of Nicotine Vaporisers Added To Smoking Cessation Treatment For Priority Populations Living With Comorbidities
Funder
National Health and Medical Research Council
Funding Amount
$1,499,145.00
Summary
Smoking is a leading cause of early death for people with certain health conditions because they are more likely to smoke and are also at greater risk of tobacco-related disease. This clinical trial will test whether encouraging people living with Hepatitis C Virus, people on opiate substitution therapy and people living with HIV who smoke to use nicotine vaporisers long-term, in addition to current smoking cessation treatments, will help them to stay abstinent from smoking.
IPrevent: Development And Pilot Testing Of An Evidence-based, Tailored, Computerised Risk Assessment And Decision Support Tool To Facilitate Discussions About Breast Cancer Prevention And Screening Measures.
Funder
National Health and Medical Research Council
Funding Amount
$415,143.00
Summary
Women at increased risk for breast cancer should be identified and offered prevention and intensified screening. Yet most women don’t know their personal risk for breast cancer. We will develop a user friendly, computerised tool which, used with her doctor, will help each woman understand her personal breast cancer risk and the benefits and disadvantages of prevention and screening strategies. It will empower women to understand and take control of their breast cancer risk.
Preventing Obesity And Promoting Healthy Body Image In Australian Secondary Schools: A Web-based System Tailored To Individual Needs
Funder
National Health and Medical Research Council
Funding Amount
$1,320,398.00
Summary
This study will test an individually tailored body image and weight management program. The program is delivered online to students in early secondary school and builds on our partnership with Stanford University adapting internet programs for use in Australia. Staying Fit Australia gives individual guidance about concerns and attitudes to weight and shape, nutrition and physical activity. The program aims to prevent obesity and promote healthy nutrition and physical activity in all adolescents.
D-Health: A Randomised Trial Of Vitamin D For Prevention Of Cancer And Mortality
Funder
National Health and Medical Research Council
Funding Amount
$2,930,705.00
Summary
There is good evidence that vitamin D is important for maintaining healthy bones. There is now a body of work suggesting that it may play a role in other diseases such as cancer, but there is not yet sufficient information to warrant screening the population to determine their vitamin D levels or recommending routine supplementation. We plan to conduct a large-scale randomised placebo-controlled trial in which we will assess the effect of vitamin D supplementation on mortality, cancer incidence ....There is good evidence that vitamin D is important for maintaining healthy bones. There is now a body of work suggesting that it may play a role in other diseases such as cancer, but there is not yet sufficient information to warrant screening the population to determine their vitamin D levels or recommending routine supplementation. We plan to conduct a large-scale randomised placebo-controlled trial in which we will assess the effect of vitamin D supplementation on mortality, cancer incidence and many other common diseases such as diabetes.Read moreRead less
Does Pneumococcal Vaccination Protect Against Cardiovascular Disease? A Randomised Placebo-controlled Double Blind Trial
Funder
National Health and Medical Research Council
Funding Amount
$1,849,245.00
Summary
Australian researchers have set up a novel multi-centre trial to investigate the effects of the pneumococcal vaccination in reducing heart attacks and stroke. People aged 55 to 61 from 6 sites around Australia will be invited to participate in the study. The selected participants will attend a clinic in their area and will be randomly given the pneumococcal vaccine or a placebo vaccine. Outcomes on the expected 6000 participants will be ascertained by health record linkage with government databa ....Australian researchers have set up a novel multi-centre trial to investigate the effects of the pneumococcal vaccination in reducing heart attacks and stroke. People aged 55 to 61 from 6 sites around Australia will be invited to participate in the study. The selected participants will attend a clinic in their area and will be randomly given the pneumococcal vaccine or a placebo vaccine. Outcomes on the expected 6000 participants will be ascertained by health record linkage with government databases after 4 years.Read moreRead less
Preventing Postnatal Depression In New Mothers Using Telephone Peer Support: A Randomised Controlled Trial
Funder
National Health and Medical Research Council
Funding Amount
$850,069.00
Summary
Depression in recent mothers are very common; more than 53,000 new mothers in Australia are affected by this each year. The condition can lead to serious adverse consequences for a mother’s health and the health of her infant and family. Effective strategies to prevent and reduce maternal depression are therefore needed. We will test whether support by telephone from other mothers (peer volunteers) helps in women at increased risk at 4 weeks postpartum.
The D-Health Trial: A Large-scale Population-based Trial Of Vitamin D Supplementation For Improving The Health Of Older Adults
Funder
National Health and Medical Research Council
Funding Amount
$2,591,860.00
Summary
The D-Health Trial is a randomised placebo-controlled trial of vitamin D supplementation for improving the health of older Australian adults. Over 21,000 people were recruited and randomised to monthly doses of vitamin D or placebo. This grant will enable completion of the planned 5 years of supplementation and long-term follow-up of mortality and cancer. The results of the trial will inform decisions about food fortification and/or supplementation with vitamin D.